A middle-aged man with short dark hair smiles at the camera. He is wearing a navy blue collared shirt and is set against a plain dark gray background.

Joseph F. Goldberg, MD

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York

  • 78Articles
  • 413.4KReads
  • 1998–2026Active
  • 121Collaborators
  • 514Citations
Back to top Open menu arrow
Early Career psychiatrists Authors and Reviewers Submit to JCP
JCP
Lurasidone and Anxiety Symptoms in Bipolar Depression
Original Research

Lurasidone and Anxiety Symptoms in Bipolar Depression

June 7, 2023

Lurasidone was superior to placebo at reducing anxiety in bipolar depression. Change in anxiety symptoms was predicted by sleep disturbance at baseline.
, , , et al
JCP
In Memoriam: Robert M. A. Hirschfeld, MD
In Memoriam

In Memoriam: Robert M. A. Hirschfeld, MD

March 20, 2023

Robert M. A. Hirschfeld is remembered as a pioneer in the phenomenology and treatment of bipolar disorder.
JCP
Addressing Unmet Needs in Bipolar Disorder
Academic Highlights

Addressing Unmet Needs in Bipolar Disorder

November 16, 2022

Bipolar disorder presents on a spectrum, with bipolar depression on one end and bipolar I on the other and a host of other presentations in between. As guidelines are...
, ,
JCP
Living in a Pharmacologically Imperfect World
Editorial

Living in a Pharmacologically Imperfect World

October 12, 2022

Joseph F. Goldberg, MD, comments on prescription of valproate in women of reproductive potential, and the risk-benefit analysis involved with choosing the least imperfect treatment option.
JCP
Recognizing Bipolar Disorder in Pregnant and Postpartum Women
Editorial

Recognizing Bipolar Disorder in Pregnant and Postpartum Women

July 13, 2022

In this editorial, Drs Freeman and Goldberg comment on a meta-analysis by Masters and colleagues on the prevalence of bipolar disorder in perinatal women.
,
JCP
Recognizing Impaired Decisional Capacity in Vaccine Refusal: Reply to Kels and Kels
Letter to the Editor

Recognizing Impaired Decisional Capacity in Vaccine Refusal: Reply to Kels and Kels

February 1, 2022

The authors reply to a letter commenting on Dr Goldberg’s JCP editorial examining COVID-19 vaccine hesitancy.
,
JCP
Commentary

Ketamine and Cognitive Function in Depression

January 4, 2022

This commentary discusses the review by Vaccarino and colleagues of cognitive effects associated with ketamine treatment for major depressive disorder.
JCP
Academic Highlights

Diagnosing and Treating Bipolar Depression

October 12, 2021

Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.
,
JCP
Editorial

How Should Psychiatry Respond to COVID-19 Anti-Vax Attitudes?

August 24, 2021

This editorial from JCP Section Editor Joseph F. Goldberg explores the psychological underpinnings of anti-vaccine attitudes and calls on psychiatrists to help combat this threat to public health.
JCP
Brief Report

Impact of Childhood Trauma History vs Recent Trauma Symptoms on Affective Lability in Bipolar Disorder

August 17, 2021

This study examined childhood trauma and current traumatic stress ratings in bipolar and unipolar inpatients to see if higher levels of childhood trauma and current trauma symptoms are associated...
, , , et al
JCP
Educational Activity

Diagnosing and Treating Bipolar Depression

July 6, 2021

Join Dr Goldberg as he reviews factors that impact the diagnosis of bipolar disorder and current treatments for bipolar depression in adults.
JCP
Letter to the Editor

Adjunctive Mood Stabilizers Are Not the Same As a Placebo-Only Arm in Bipolar Depression Trials: Reply to Terao

June 22, 2021

Dr Goldberg responds to Dr Terao’s letter regarding a study of citalopram for bipolar depression.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe